Compaction assay: a rapid and simple in vitro method to assess the responsiveness of a biopolymer matrix to enzymatic modification

Biomaterials. 1995 May;16(7):553-8. doi: 10.1016/0142-9612(95)91129-m.

Abstract

A rapid and simple in vitro method is described which measures the extent of unrecoiled solids compression when a complex biopolymer is subjected to a centrifugal force. This method, termed the compaction assay, was used to assess the response of purulent cystic fibrosis (CF) sputum samples to the addition of recombinant human deoxyribonuclease I (rhDNase). Enzyme treatment resulted in a dramatic decrease in DNA size, a redistribution of total DNA content from the pellet to supernatant, a significant decrease in that pellet volume and a decrease in elastic modulus. Sample elasticity, measured by a dynamic cone and plate viscometer, could be related to compaction assay results. These results suggest that the compaction assay may be a useful in vitro method for rapidly assessing the actions of enzymatic disruption of a complex biopolymer, such as that observed for the actions of rhDNase on purulent airway secretions.

Publication types

  • Comparative Study

MeSH terms

  • Biocompatible Materials / standards
  • Biomechanical Phenomena
  • Biopolymers
  • Cloning, Molecular
  • Cystic Fibrosis / enzymology
  • Cystic Fibrosis / pathology*
  • DNA / metabolism
  • Deoxyribonuclease I / genetics
  • Deoxyribonuclease I / pharmacology*
  • Electrophoresis, Agar Gel
  • Humans
  • In Vitro Techniques
  • Molecular Weight
  • Recombinant Proteins / genetics
  • Recombinant Proteins / pharmacology
  • Rheology
  • Sputum / chemistry
  • Sputum / drug effects
  • Sputum / metabolism*
  • Viscosity

Substances

  • Biocompatible Materials
  • Biopolymers
  • Recombinant Proteins
  • DNA
  • Deoxyribonuclease I